Effect and mechanism of Sanqi danshen tablets in the treatment of non-alcoholic fatty liver disease

LEI Yutian; FENG Dan; CHEN Xinli; YANG Yuan; WU Hui

doi:10.6039/j.issn.1001-0408.2025.06.06

您当前的位置：

首页 >

文章列表页 >

Effect and mechanism of Sanqi danshen tablets in the treatment of non-alcoholic fatty liver disease

更新时间：2025-09-25

- Effect and mechanism of Sanqi danshen tablets in the treatment of non-alcoholic fatty liver disease
- ZHONGGUO YAOFANG Vol. 36, Issue 6, Pages: 674-679(2025)
- 作者机构：
  
  昆明医科大学第一附属医院临床药学中心，昆明　650032
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2025.06.06
  CLC： R965;R285.5
- Received：30 July 2024，
  
  Revised：2025-01-07，
  
  Accepted：21 January 2025，
  
  Published：30 March 2025
- 稿件说明：
移动端阅览
雷雨田,冯丹,陈新利,等.三七丹参片治疗非酒精性脂肪性肝病的作用机制研究[J].中国药房,2025,36(06):674-679.

LEI Yutian,FENG Dan,CHEN Xinli,et al.Effect and mechanism of Sanqi danshen tablets in the treatment of non-alcoholic fatty liver disease[J].ZHONGGUO YAOFANG,2025,36(06):674-679.
雷雨田,冯丹,陈新利,等.三七丹参片治疗非酒精性脂肪性肝病的作用机制研究[J].中国药房,2025,36(06):674-679. DOI： 10.6039/j.issn.1001-0408.2025.06.06.

LEI Yutian,FENG Dan,CHEN Xinli,et al.Effect and mechanism of Sanqi danshen tablets in the treatment of non-alcoholic fatty liver disease[J].ZHONGGUO YAOFANG,2025,36(06):674-679. DOI： 10.6039/j.issn.1001-0408.2025.06.06.

摘要

目的

探讨三七丹参片治疗非酒精性脂肪性肝病（NAFLD）的潜在机制。

方法

采用网络药理学方法，挖掘三七丹参片治疗NAFLD的核心靶点，并进行基因本体（GO）功能及京都基因和基因组数据库（KEGG）通路富集分析。基于网络药理学结果，以SD大鼠为对象，以高脂饲料喂养构建NAFLD模型，考察三七丹参片对NAFLD大鼠肝组织脂滴空泡、脂质蓄积等病理改变以及脂质代谢、炎症反应、氧化应激指标的影响。

结果

共筛选出三七丹参片治疗NAFLD的核心靶点20个，主要涉及生物调节、细胞膜、结合等GO功能，并富集于炎症反应、氧化应激、脂质代谢相关信号通路。动物实验显示，与模型组相比，三七丹参片低、中、高剂量组和阳性对照药（辛伐他汀）组大鼠肝组织内脂滴空泡明显减少，脂滴数量明显减少且颜色变浅；其肝组织中总胆固醇、甘油三酯（三七丹参片中剂量组除外）、天冬氨酸转氨酶、丙氨酸转氨酶、肿瘤坏死因子α（三七丹参片低剂量组除外）、白细胞介素17（三七丹参片各剂量组除外）、丙二醛（三七丹参片低剂量组除外）含量均显著降低，超氧化物歧化酶含量均显著升高（

＜0.01或

＜0.05）。

结论

三七丹参片可通过影响炎症反应、氧化应激、脂质代谢等相关指标含量来发挥抗炎、抗氧化、调节脂质代谢的作用，从而改善大鼠的NAFLD。

Abstract

OBJECTIVE

To investigate the potential mechanism of Sanqi danshen tablets in the treatment of non-alcoholic fatty liver disease （NAFLD）.

METHODS

Core targets of Sanqi danshen tablets in the treatment of NAFLD were explored by network pharmacological methods. Gene ontology （GO） functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes （KEGG） pathway enrichment analysis were also performed. Based on the results obtained from network pharmacological studies， using SD rats as subjects， the NAFLD model was induced by feeding them high-fat diet. The effects of Sanqi danshen tablets on pathological changes such as lipid droplet vacuoles and lipid accumulation in the liver tissue of NAFLD rats， as well as its impact on relative indicators of lipid metabolism， inflammatory responses and oxidative stress， were investigated.

RESULTS

A total of 20 core targets for the treatment of NAFLD with Sanqi danshen tablets were screened， primarily involved in GO functions such as biological regulation， cellular membrane and binding， and enriched in signaling pathways related to inflammatory responses， oxidative stress and lipid metabolism. Compared with the model group， lipid droplet vacuoles were reduced significantly in low-dose， medium-dose， high-dose groups of Sanqi danshen tablets and positive control （simvastatin） group， the number of lipid droplets decreased significantly and the color became lighter. The contents of total cholesterol， triglyceride （except for medium-dose group of Sanqi danshen tablets）， aspartate transaminase， alanine transaminase， tumor necrosis factor-α （except for low-dose group of Sanqi danshen tablets）， interleukin-17 （except for Sanqi danshen tablets groups） and malondialdehyde （except for low-dose group of Sanqi danshen tablets） in liver tissue were significantly decreased， while the content of superoxide dismutase was significantly increased （

＜0.01 or

＜0.05）.

CONCLUSIONS

Sanqi danshen tablets exert anti-inflammatory， antioxidant and lipid metabolism regulating effects by influencing the levels of inflammation， oxidative stress and lipids metabolism-related indicators， thereby improving NAFLD in rats.

关键词

Keywords

references

赵瀚东，杨帆，詹丽 . 非酒精性脂肪性肝病发病机制研究进展 [J ] . 解放军医学院学报， 2022 ， 43 （ 3 ）： 366 - 371 .

ZHAO H D ， YANG F ， ZHAN L . Research advances in pathogenesis of non-alcoholic fatty liver disease [J ] . Acad J Chin PLA Med Sch ， 2022 ， 43 （ 3 ）： 366 - 371 .

EKSTEDT M ， NASR P ， KECHAGIAS S . Natural history of NAFLD/NASH [J ] . Curr Hepatol Rep ， 2017 ， 16 （ 4 ）： 391 - 397 .

FRANCQUE S ， SZABO G ， ABDELMALEK M F ， et al . Nonalcoholic steatohepatitis：the role of peroxisome proliferator-activated receptors [J ] . Nat Rev Gastroenterol Hepatol ， 2021 ， 18 （ 1 ）： 24 - 39 .

CHALASANI N ， YOUNOSSI Z ， LAVINE J E ， et al . The diagnosis and management of nonalcoholic fatty liver di-sease：practice guidance from the American Association for the Study of Liver Diseases [J ] . Hepatology ， 2018 ， 67 （ 1 ）： 328 - 357 .

CUSI K ， ISAACS S ， BARB D ， et al . American Asso-ciation of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings：co-sponsored by the American Association for the Study of Liver Diseases（AASLD） [J ] . Endocr Pract ， 2022 ， 28 （ 5 ）： 528 - 562 .

中华医学会肝病学分会脂肪肝和酒精性肝病学组，中国医师协会脂肪性肝病专家委员会 . 非酒精性脂肪性肝病防治指南：2018更新版 [J ] . 现代医药卫生， 2018 ， 34 （ 5 ）： 641 - 649 .

National Workshop on Fatty Liver and Alcoholic Liver Disease ， Chinese Society of Hepatology ， Fatty Liver Expert Committee of Chinese Medical Doctor Association . Guideline of prevention and treatment for non-alcoholic fatty liver disease：a 2018 update [J ] . J Mod Med Health ， 2018 ， 34 （ 5 ）： 641 - 649 .

孙超，范建高 . 中外非酒精性脂肪性肝病诊疗指南解读 [J ] . 中国实用内科杂志， 2019 ， 39 （ 3 ）： 235 - 238 .

SUN C ， FAN J G . Interpretation of Chinese and foreign guidelines for the diagnosis and management of non-alcoholic fatty liver disease [J ] . Chin J Pract Intern Med ， 2019 ， 39 （ 3 ）： 235 - 238 .

冯晓异，何朋伦，赵微，等 . 三七总皂苷对非酒精性脂肪肝大鼠的改善作用及对NO/iNOS/NF-κB通路的影响 [J ] . 中成药， 2021 ， 43 （ 1 ）： 50 - 55 .

FENG X Y ， HE P L ， ZHAO W ， et al . Effects of Panax notoginseng total saponins on improving non -alcoholic fatty liver disease rats and NO/iNOS/NF-κB signaling pathway [J ] . Chin Tradit Pat Med ， 2021 ， 43 （ 1 ）： 50 - 55 .

张声生，吴震宇，陈剑明，等 . 三七总皂苷改善高脂诱导脂肪肝大鼠模型氧化应激及胰岛素抵抗的研究 [J ] . 中国中西医结合杂志， 2014 ， 34 （ 1 ）： 56 - 61 .

ZHANG S S ， WU Z Y ， CHEN J M ， et al . Study on the mechanism of action of total saponins of Panax notoginseng in ameliorating oxidative stress and insulin resistance in rats fed with high fat diet [J ] . Chin J Integr Tradit West Med ， 2014 ， 34 （ 1 ）： 56 - 61 .

秦智，周敏 . 丹参酮Ⅱ A 通过Nrf2信号通路抑制肝组织铁死亡对非酒精性脂肪肝大鼠肝脏的保护作用 [J ] . 中国中药杂志， 2024 ， 49 （ 6 ）： 1611 - 1620 .

QIN Z ， ZHOU M . Tanshinone Ⅱ A inhibits ferroptosis via Nrf2 signaling pathway to protect liver in rats of non-alcoholic fatty liver disease [J ] . China J Chin Mater Med ， 2024 ， 49 （ 6 ）： 1611 - 1620 .

钱林惠 . 三七丹参片治疗非酒精性脂肪性肝病的真实世界研究 [D ] . 昆明：昆明医科大学， 2023 .

QIAN L H . Real-world study on the treatment of non-alcoholic fatty liver disease with Sanqi danshen tablets [D ] . Kunming ： Kunming Medical University ， 2023 .

VUGMEYSTER Y ， HARROLD J ， XU X . Absorption，distribution，metabolism，and excretion（ADME）studies of biotherapeutics for autoimmune and inflammatory conditions [J ] . AAPS J ， 2012 ， 14 （ 4 ）： 714 - 727 .

CHIN C H ， CHEN S H ， WU H H ， et al . cytoHubba：identifying hub objects and sub-networks from complex interactome [J ] . BMC Syst Biol ， 2014 ， 8 （ Suppl. 4 ）： S11 .

乌日嘎，威力斯，乌日拉嘎，等 . 匝迪-5味丸改善心肌缺血再灌注损伤的作用机制预测及验证 [J ] . 中国药房， 2024 ， 35 （ 4 ）： 442 - 448 .

WURIGA ， WEILISI ， WURILAGA ， et al . Prediction and validation of the mechanism of Zadi-5 pill in protecting myocardial ischemia-reperfusion injury [J ] . China Pharm ， 2024 ， 35 （ 4 ）： 442 - 448 .

谭丹枫，陶月英，姜媛，等 . 胆石六号颗粒对模型小鼠非酒精性脂肪肝的改善作用研究 [J ] . 中国药房， 2018 ， 29 （ 22 ）： 3106 - 3110 .

TAN D F ， TAO Y Y ， JIANG Y ， et al . Study on improvement effects of Danshi Ⅵ granules on non-alcoholic fatty liver disease in model mice [J ] . China Pharm ， 2018 ， 29 （ 22 ）： 3106 - 3110 .

何峰，张雪莲，温祥臣 . 山楂酸对高脂饮食诱导的非酒精性脂肪肝模型小鼠炎症反应及氧化应激的影响 [J ] . 中国药房， 2019 ， 30 （ 7 ）： 901 - 905 .

HE F ， ZHANG X L ， WEN X C . Effects of crataegolic acid on inflammatory response and oxidative stress in non-alcoholic fatty liver disease model mice induced by high-fat diet [J ] . China Pharm ， 2019 ， 30 （ 7 ）： 901 - 905 .

SONG Y ， YANG J M . Role of interleukin（IL）-17 and T-helper（Th） 17 cells in cancer [J ] . Biochem Biophys Res Commun ， 2017 ， 493 （ 1 ）： 1 - 8 .

ASSUNÇÃO S N F ， SORTE N C A B ， ALVES C A D ， et al . Inflammatory cytokines and non-alcoholic fatty liver disease（NAFLD）in obese children and adolescents [J ] . Nutr Hosp ， 2018 ， 35 （ 1 ）： 78 - 83 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research progress on mechanism of antidepressant action of curcumin

Protective effect of marein against alcoholic fatty liver and its mechanism

Effects and mechanism of Hugan buzure formula on intrahepatic cholestatic liver injury in rats

Study on protective effect and mechanism of Arisaema Cum Bile on acute liver injury induced by CCl₄ in mice

Improvement effects of tilianin on atherosclerosis model mice and its mechanism study

Related Author

ZHOU Ce

FU Hao

XI Yuting

ZHOU Jianping

SONG Huafeng

NIU Guanghao

GU Yuren

XU Ying

Related Institution

Dept. of Anorectology， Hospital of Chengdu University of Traditional Chinese Medicine

Dept. of Anorectology， Zigong Hospital of Traditional Chinese Medicine

Clinical Trial Institution Office， the Fifth People’s Hospital of Suzhou （the Affiliated Infectious Diseases Hospital of Soochow University）

Inspection Center， the Fifth People’s Hospital of Suzhou （the Affiliated Infectious Diseases Hospital of Soochow University）

College of Pharmacy， Xinjiang Medical University

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰